title: High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival.
abstract: Alterations in the PI3K/Akt pathway, a pathway that promotes proliferation and oncogenic transformation, are common in various cancers. In neuroblastoma, activation of Akt is correlated with aggressive disease although mutations in genes of this pathway are rare. Previous findings include a few mutations in PIK3CD, the gene encoding PI3K catalytic subunit delta, p110δ. We recently reported that an alternatively spliced form of p110δ, called p37δ, had cell proliferative properties and was over-expressed in ovarian and colorectal tumors. Here, we investigated p37δ in neuroblastoma primary tumors of different stages using qPCR (TaqMan) for gene expression analysis (46 samples) and Western blot for protein analysis (22 samples). Elevated levels of both p37δ-mRNA and p110δ-mRNA were detected in metastasizing neuroblastoma tumors compared to normal adrenal gland (P < 0.05), and higher expression of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma non-survivor patients compared to survivors (P < 0.01). p37δ-Protein levels but not p110δ levels correlated with increased pAKT(T308) and pERK levels. The p37δ-mRNA levels did not correlate with the protein levels, indicating major regulation at the translational/protein level. Deregulation of signaling pathways is a hallmark of cancer development. Here, we show that p37δ, a kinase-dead isoform of the PI3K catalytic subunit p110δ, is over-expressed in neuroblastoma tumors, and that it correlates with the activation of both PI3K/Akt- and RAS-signaling pathways.
authors.affiliation: Department of Medical and Clinical Genetics, Sahlgrenska Cancer Center, University of Gothenburg, Box 425, 405 30, Göteborg, Sweden.
authors.forename: Susanne
authors.initials: S
authors.lastname: Fransson
authors.forename: Katarina
authors.initials: K
authors.lastname: Ejeskär
mesh_terms: D000311:Adrenal Glands / Q000473:pathology; D002384:Catalysis; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D006801:Humans; D020935:MAP Kinase Signaling System / Q000235:genetics; D009447:Neuroblastoma / Q000235:genetics* / Q000401:mortality* / Q000473:pathology; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D021122:Protein Subunits / Q000235:genetics; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics
chemical_list: D021122:Protein Subunits; D012333:RNA, Messenger; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt
references.citation: Oncogene. 2008 May 1;27(20):2910-22
references.pmid: 18026138
references.citation: Oncogene. 2008 Apr 17;27(18):2561-74
references.pmid: 17998941
references.citation: J Biol Chem. 1997 Aug 1;272(31):19236-41
references.pmid: 9235916
references.citation: Biochem J. 2012 May 1;443(3):857-67
references.pmid: 22375552
references.citation: Med Pediatr Oncol. 2001 Jan;36(1):61-6
references.pmid: 11464908
references.citation: Oncogene. 2008 Sep 18;27(41):5486-96
references.pmid: 18794883
references.citation: Cell. 2007 Jun 29;129(7):1261-74
references.pmid: 17604717
references.citation: Oncogene. 2012 Jul 5;31(27):3277-86
references.pmid: 22020336
references.citation: Genes Chromosomes Cancer. 2007 Jan;46(1):45-52
references.pmid: 17044048
references.citation: J Mol Signal. 2013 Apr 18;8(1):4
references.pmid: 23597230
references.citation: Cancer Res. 2007 Jan 15;67(2):735-45
references.pmid: 17234785
references.citation: Trends Biochem Sci. 2005 Apr;30(4):194-204
references.pmid: 15817396
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):1172-81
references.pmid: 18281552
references.citation: Nature. 2008 Aug 7;454(7205):776-9
references.pmid: 18594509
references.citation: PLoS One. 2007 Sep 11;2(9):e869
references.pmid: 17846664
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4330-5
references.pmid: 9113989
references.citation: Int J Oncol. 2013 Feb;42(2):609-16
references.pmid: 23232578